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Abstract
A 39-year-old man, followed with serial MRI of CNS for a radiologically 
isolate syndrome (RIS, a recently described condition considered a subclinical 
form of MS), was hospitalized for the occurrence of a leptomeningitis. Routine 
blood tests and contrast enhanced total body CT scan were unremarkable. 
Cerebrospinal fluid (CSF) examination showed increase of cells (22 mononuclear 
cells/mm3), albumin (294 mg/L), immunoglobilins G (161 mg/L) and Link 
Index (1.9), with 17 oligoclonal bands. Microbiological examinations of CSF 
(including those for Koch's Bacillus) were negative. The Mantoux reaction and 
the QuantiFERON test were positive, featuring a latent tuberculosis (TB). The 
patient started prophylaxis with rifampicin and isoniazid for four months, until 
a new MRI showed the disappearance of the leptomeningeal enhancement, 
and the stability of white matter brain and spinal cord lesions. Two other MRI 
scans showed a new brain Gd-enhancing lesion nine month after anti-tubercular 
therapy and, after additional six months, new cerebral and spinal cord areas. 
This case provides the following suggestions about the effects of TB infection 
and related therapies on the underlying autoimmune status: the infection, while 
actively present, did not exacerbate the RIS condition; the worsening nine months 
after the prophylaxis discontinuation might have been the 'natural' evolution of 
RIS condition. Alternative speculative hypotheses include a remote effect of the 
infection, of isoniazid (that was reported in some cases to trigger MS), or the 
result of the clearance of the infection itself. Irrespective of the existence of any 
interaction between RIS and TB infection, It seems important to collect cases 
with MS-related diseases and concomitant infections, that may provide clues 
about disease pathogenesis and treatment.
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Introduction 
Tuberculous meningitis (TBM) is a rare and severe manifestation of extra-
pulmonary tuberculosis, characterized by headache, vomiting, meningeal signs, 
focal deficits, vision loss, cranial nerve palsies and raised intracranial pressure. The 
differential diagnosis of TBM includes other infectious disease, inflammatory 
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diseases of leptominges and meningeal carcinomatosis. 
Tuberculosis of the central nervous system is a still major cause 
of death or significant neurological disability. Consequently, 
prompt diagnosis and early treatment are of the utmost 
importance and magnetic resonance imaging (MRI) is of great 
help. 
We describe a case of probable TBM, occurring in a 
person with radiologically isolated syndrome (RIS). RIS is a 
new entity, diagnosed when the unanticipated MRI finding 
of brain spatial dissemination of focal white matter (WM) 
lesions highly suggestive of multiple sclerosis (MS) occurs in 
subjects without symptoms typical of MS, and with normal 
neurological examinations [1]. Approximately one-third and 
two-thirds of individuals respectively experience clinical onset 
and/or radiological progression over a mean follow-up of five 
years [1]. However, predictors (male sex, age < 37, spinal cord 
involvement) of higher risk of progression have been identified 
and conversion to clinically isolated syndromes (CIS) was 
described in 84% of RIS individuals with spinal cord lesions 
over a median time of 1.6 years from the date of the first 
MRI [2]. Being RIS condition in many instances a form of 
subclinical MS, our case may have relevance to understand the 
relationship between neuroinflammation and Mycobacterium 
tuberculosis.
Case Report
A 39-year-old man, experienced transient (less than 4 
hours) and migrating paresthesia (head, tongue, upper limbs). 
For this disturbance he performed an MRI scan of brain and 
spinal cord that revealed white matter lesions, compatible with 
inflammatory demyelinating lesions of the brain (Figure 1A-
D). Not having history of previous clinical events, and the 
reported symptoms being nonspecific, the subject fulfilled the 
criteria for RIS [1]. 
A second MRI scan, performed after two months to check 
possible evolution (in the absence of symptoms or signs), 
showed cerebral edema with leptomeningeal enhancement 
in the left frontal cortex (Figure 2A-C, arrows). Because of 
this MRI picture the subject was hospitalized and a diagnostic 
process was implemented. The following exams were normal: 
routine blood tests and protein electrophoresis, serology for 
herpes viruses (cytomegalovirus, Epstein-Barr virus, Varicella 
zoster, Herpes simplex 1/2) hepatitis viruses (B and C) 
HIV, Treponema pallidum, Borrelia burgdoferi, Mycoplasma, 
Chlamydia, Toxoplasma, Brucella, Aspergillus and Candida, 
oncomarkers, autoantibodies, C3, C4, folate and vitamin 
B12. Typing for HLA-B*08, HLA-B*27 was negative. The 
radiological picture remained substantially unchanged at a 
third MRI exam (twenty days after hospitalization).
Cerebrospinal fluid (CSF) was clear and showed the 
following data: 22 mononuclear cells/mm3, glucose 64 mg/dl, 
protein 54.1 mg/dl, increased albumin (294 mg/L), IgG (161 
mg/L) and Link Index (1.9), with presence of 17 oligoclonal 
bands (type two pattern). Microbiological examination of 
CSF (microscopy for common germs and Koch’s Bacillus 
(BK), bacterial culture for common germs and BK, PCR for 
neurotropic viruses and BK, direct search for cryptococcus 
antigen and cryptococcus culture) was negative. CSF 
cytology showed marked lymphocytosis without patterns 
of lymphoproliferative diseases. A total body computerized 
tomography was normal. Standard and sleep deprivation 
electroencephalogram showed very modest electrical 
alterations in frontal lobes with left prevalence. The Monteux 
Intradermal reaction resulted positive (an infiltrate diameter 
> 5 mm). Accordingly, QuantiFERON test was positive (> 4; 
normal range 0.00-0.35). A diagnosis of probable TBM was 
done, even though we were not able to shed light on further 
etiologic cues: the patient is a white man, with a negative 
history for past contact with TB cases, as well as for relevant 
past medical conditions.
During hospitalization, the patient underwent a 
cycle of 21 days of therapy with acyclovir, and then started 
Rifampicin 600 mg and Isoniazid 300 mg daily, with B6 
Figure 1: (A-G) First MRI examination. T2 FLAIR images showed 
white matter lesions compatible with inflammatory pathogenesis. 
Figure 2: (A-F) Second MRI examination after two months. (A) In 
the rolandic subarachnoid spaces and in the inter-emispheric region is 
evident a reduced visualization of subarachnoid spaces in T2 FLAIR. 
(C) Mild enhancement after gadolinium injection. (F) After 5 months 
this enhancement decreased, (D) a reduced visualization of subarachnoid 
spaces remained.
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vitamin 300 mg daily, which continued for four months, until 
a new MRI showed the disappearance of the leptomeningeal 
enhancement, and the stability of white matter brain and 
spinal cord demyelinating lesions (Figure 2D-F, arrows). He 
has been followed with serial MRIs: nine months after anti-
tubercular therapy discontinuation a new MRI showed a new 
brain Gd-enhancing lesion and after additional six months 
(last MRI scan) new cerebral and spinal cord areas appeared, at 
level of C2-C3 and C5-C6, without gadolinium enhancement 
(Figure 3A-C). Currently the patient remains asymptomatic.
Discussion 
This case raises two points: one is more pragmatic and 
concerns the clinical management of patients with apparent 
CNS complication of Mycobacterium tuberculosis, in the absence 
of a direct demonstration of the microbe; the other one is more 
complex and deals with the relationship between mycobacteria 
and neuroinflammation. Concerning the first point, the lack 
of microscopic, cultural or PCR evidence of mycobacterium 
is not a rare event. Nonetheless, with positive Mantoux test 
and QuantiFeron, the preventive therapy for latent TB is 
indicated for 3 months. The disappearance of leptomeningeal 
involvement after anti-TB treatment indirectly supports the 
mycobacterial etiology.
The relationship between mycobacteria and 
neuroinflammation is multifaceted. It is known that 
mycobacteria, as components of complete Freund adjuvant, are 
needed together with myelin auto-antigens to induce the animal 
model of MS experimental autoimmune encephalomyelitis 
(EAE). However, the so-called “adjuvant approach” has 
long been known to be protective for EAE: the observation 
is that the exposure to mycobacterium or Freund adjuvant 
before immunization with myelin autoantigens prevents 
the development of EAE. Along this line, vaccination with 
Bacillus Calmette-Guerin (BCG) seems to be beneficial in 
neuroinflammation, reducing MRI disease activity in patients 
with early MS and in people with CIS, where a preventive 
effect on conversion to definite MS was also observed [3, 
4]. In the context of the relationship between mycobacteria 
and neuroinflammation there are recent investigations on 
the association between Mycobacterium avium subspecies 
paratubercolosis (MAP) and MS in Sardinia: significant 
differences between patients and controls in MAP DNA 
and humoral response against MAP proteins were reported, 
along with the presence of antibodies cross-recognizing 
MAP epitopes and myelin epitopes in sera and cerebrospinal 
fluid of MS patients [5]. Lastly, the possible effects of anti-
tubercular treatments on neuroinflammation should be taken 
into account. The case of a patient with diagnosis of primary 
progressive MS and concomitant isoniazid (INH) therapy, 
started after positivity of tuberculin skin test, was recently 
described. The authors hypothesized that INH, in a genetically 
susceptible individual, may activate CNS auto-reactive T cells 
and ultimately initiate a demyelinating disease [6].
Conclusion
A single case report, also with some uncertainties about 
the diagnosis of tuberculosis, does not allow to draw firm 
conclusions about the effects of the infection and related 
therapies on the underlying autoimmune status. The infection, 
while actively present, did not exacerbate the RIS condition. 
The lack of any interaction between these concomitant events 
is plausible: the MRI progression may represent a ‘natural’ 
evolution of the RIS condition. Alternative, speculative 
hypotheses to explain the worsening after nine months from 
anti-tubercular therapy discontinuation might be a remote 
effect of the infection, or of isoniazid [6], or the result of the 
clearance of the infection itself. Irrespective of the existence 
of any interplay between RIS and TBM, it is important to 
collect experience on cases of neuroinflammatory diseases and 
concomitant infectious conditions since this effort may provide 
answers to important questions about disease pathogenesis 
and treatment.  
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Figure 3: (A-C) MRI follow-up. New lesions in cervical spinal cord were 
evident.
